Molecular Mechanisms behind Obesity and Their Potential Exploitation in Current and Future Therapy
International Journal of Molecular Sciences · 27.07.2024 · 25 (15) · 8202
DOI: 10.3390/ijms25158202 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 27.07.2024. Verfasst von Michał Nicze und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine and Clinical Pharmacology, Faculty of Medical Sciences, Medical University of Silesia in Katowice, Medyków 18, 40-752…. Hauptthemen laut MEDLINE: Obesity, Anti-Obesity Agents. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 299 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical University of Silesia, National Science Center.
Abstract (Originalsprache)
Obesity is a chronic disease caused primarily by the imbalance between the amount of calories supplied to the body and energy expenditure. Not only does it deteriorate the quality of life, but most importantly it increases the risk of cardiovascular diseases and the development of type 2 diabetes mellitus, leading to reduced life expectancy. In this review, we would like to present the molecular pathomechanisms underlying obesity, which constitute the target points for the action of anti-obesity medications. These include the central nervous system, brain–gut–microbiome axis, gastrointestinal motility, and energy expenditure. A significant part of this article is dedicated to incretin-based drugs such as GLP-1 receptor agonists (e.g., liraglutide and semaglutide), as well as the brand new dual GLP-1 and GIP receptor agonist tirzepatide, all of which have become “block-buster” drugs due to their effectiveness in reducing body weight and beneficial effects on the patient’s metabolic profile. Finally, this review article highlights newly designed molecules with the potential for future obesity management that are the subject of ongoing clinical trials.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Internal Medicine and Clinical Pharmacology, Faculty of Medical Sciences, Medical University of Silesia in Katowice, Medyków 18, 40-752 Katowice, Poland.
ORCID-Profile: Michał Nicze, Maciej Borówka, Łukasz Bułdak, Bogusław Okopień
Förderung
- Medical University of Silesia
- National Science Center
Zitieren
APA
Nicze, M., Dec, A., Borówka, M., Krzyżak, D., Bołdys, A., Bułdak, Ł., & Okopień, B. (2024). Molecular Mechanisms behind Obesity and Their Potential Exploitation in Current and Future Therapy. International Journal of Molecular Sciences, 25(15), 8202. https://doi.org/10.3390/ijms25158202
Vancouver
Nicze M, Dec A, Borówka M, Krzyżak D, Bołdys A, Bułdak Ł, et al. Molecular Mechanisms behind Obesity and Their Potential Exploitation in Current and Future Therapy. International Journal of Molecular Sciences. 2024;25(15):8202. doi:10.3390/ijms25158202
BibTeX
@article{Nicze2024,
author = {Nicze, Michał and Dec, Adrianna and Borówka, Maciej and Krzyżak, Damian and Bołdys, Aleksandra and Bułdak, Łukasz and Okopień, Bogusław},
title = {Molecular Mechanisms behind Obesity and Their Potential Exploitation in Current and Future Therapy},
journal = {International Journal of Molecular Sciences},
year = {2024},
volume = {25},
number = {15},
pages = {8202},
doi = {10.3390/ijms25158202}
}
EUVIMED